T1	Pharmacological_substance 10 19	Cisplatin
N1000 	Reference T1 MeSH:D002945	Cisplatin
T4	Disorder 76 81	SIADH
N1 	Reference T4 UMLS:C0021141	SIADH
T5	Disorder 101 121	neuroendocrine tumor
N2 	Reference T5 UMLS:C0206754	neuroendocrine tumor
T7	Pharmacological_substance 275 284	cisplatin
N1001 	Reference T7 MeSH:D002945	cisplatin
T8	Disorder 311 361	advanced-stage large cell neuroendocrine carcinoma
T9	Pharmacological_substance 416 425	cisplatin
N1002 	Reference T9 MeSH:D002945	cisplatin
T10	Pharmacological_substance 465 476	Carboplatin
N1003 	Reference T10 MeSH:D016190	Carboplatin
T12	Pharmacological_substance 497 506	cisplatin
N1004 	Reference T12 MeSH:D002945	cisplatin
T13	Disorder 546 551	SIADH
N3 	Reference T13 UMLS:C0021141	SIADH
T2	Disorder 207 253	syndrome of inappropriate antidiuretic hormone
N4 	Reference T2 UMLS:C0021141	syndrome of inappropriate antidiuretic hormone
T3	Disorder 255 260	SIADH
N5 	Reference T3 UMLS:C0021141	SIADH
T6	Disorder 28 74	syndrome of inappropriate antidiuretic hormone
N6 	Reference T6 UMLS:C0021141	syndrome of inappropriate antidiuretic hormone
T16	Negation_cue 523 533	no further
T18	Subject 86 95	a patient
T19	Subject 296 305	a patient
